Pharsight

Drugs that contain Albuterol Sulfate

1. Accuneb patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6702997 MYLAN SPECIALITY LP Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
Dec, 2021

(2 years ago)

Market Authorisation Date: 30 April, 2001

Treatment: Indicated for the relief of bronchospasm in patients 2-12 years of age with asthma (reversible obstructive airway disease)

Dosage: SOLUTION;INHALATION

How can I launch a generic of ACCUNEB before it's drug patent expiration?
More Information on Dosage

ACCUNEB family patents

Family Patents

2. Proair Digihaler patents expiration

PROAIR DIGIHALER's oppositions filed in EPO
PROAIR DIGIHALER IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6748947 TEVA BRANDED PHARM De-agglomerator for breath-actuated dry powder inhaler
Jun, 2021

(2 years ago)

US6701917 TEVA BRANDED PHARM Dose counter for medicament inhaler
Jun, 2021

(2 years ago)

US6871646 TEVA BRANDED PHARM De-agglomerator for breath-actuated dry powder inhaler
Jun, 2021

(2 years ago)

US8006690 TEVA BRANDED PHARM Reservoir pressure system for medicament inhaler
Jun, 2021

(2 years ago)

US6718972 TEVA BRANDED PHARM Dose metering system for medicament inhaler
Jun, 2021

(2 years ago)

US7540282 TEVA BRANDED PHARM Reservoir pressure system for medicament inhaler
May, 2023

(1 year, 25 days ago)

US10765820 TEVA BRANDED PHARM Dry powder inhalation apparatus
May, 2025

(11 months from now)

US9463288 TEVA BRANDED PHARM Dry powder inhalation apparatus
May, 2025

(11 months from now)

US8651103 TEVA BRANDED PHARM Dry powder inhalation apparatus
Mar, 2028

(3 years from now)

US10124131 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(6 years from now)

US9731087 TEVA BRANDED PHARM Dose counter for inhaler having a bore and shaft arrangement
May, 2031

(6 years from now)

US10022510 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
May, 2031

(6 years from now)

US9216260 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
Jun, 2031

(7 years from now)

US10561808 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
Jan, 2032

(7 years from now)

US8978966 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
Jan, 2032

(7 years from now)

US9782551 TEVA BRANDED PHARM Compliance monitoring module for a breath-actuated inhaler
Aug, 2035

(11 years from now)

US9782550 TEVA BRANDED PHARM Compliance monitoring module for a breath-actuated inhaler
Aug, 2035

(11 years from now)

US10918816 TEVA BRANDED PHARM Compliance monitoring module for a breath-actuated inhaler
Dec, 2035

(11 years from now)

US10569034 TEVA BRANDED PHARM Compliance monitoring module for a breath-actuated inhaler
Aug, 2036

(12 years from now)

US11351317 TEVA BRANDED PHARM Drug delivery device with electronics
Feb, 2038

(13 years from now)

US11357935 TEVA BRANDED PHARM Drug delivery device with electronics
Sep, 2038

(14 years from now)

US11000653 TEVA BRANDED PHARM Inhaler
Dec, 2038

(14 years from now)

US11344685 TEVA BRANDED PHARM Drug delivery device with electronics
Sep, 2039

(15 years from now)

US11439777 TEVA BRANDED PHARM Drug delivery device with electronics
May, 2040

(15 years from now)

US11464923 TEVA BRANDED PHARM Inhaler system
Jun, 2040

(16 years from now)

US11173259 TEVA BRANDED PHARM Drug delivery device with electronics and power management
Jul, 2040

(16 years from now)

US11266796 TEVA BRANDED PHARM Inhalation device with integrated electronics
Feb, 2041

(16 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Mar 12, 2018
New Patient Population(NPP) Apr 28, 2019

Market Authorisation Date: 21 December, 2018

Treatment: NA

Dosage: POWDER, METERED;INHALATION

More Information on Dosage

PROAIR DIGIHALER family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Proair Hfa patents expiration

PROAIR HFA IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5605674 TEVA BRANDED PHARM Medicinal aerosol formulations
Feb, 2014

(10 years ago)

US7566445 TEVA BRANDED PHARM Medicinal aerosols and methods of delivery thereof
Jun, 2017

(6 years ago)

US8834849 TEVA BRANDED PHARM Medicinal aerosols and methods of delivery thereof
Jun, 2017

(6 years ago)

US6446627 TEVA BRANDED PHARM Inhaler dose counter
Dec, 2017

(6 years ago)

US7105152 TEVA BRANDED PHARM Suspension aerosol formulations
Sep, 2023

(8 months ago)

US8132712 TEVA BRANDED PHARM Metered-dose inhaler
Sep, 2028

(4 years from now)

US10086156 TEVA BRANDED PHARM Dose counter for inhaler and method for counting doses
May, 2031

(6 years from now)

US9808587 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(6 years from now)

US9463289 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
May, 2031

(6 years from now)

US10022510 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
May, 2031

(6 years from now)

US10695512 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(6 years from now)

US11395889 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(6 years from now)

US10022509 TEVA BRANDED PHARM Dose counter for inhaler having a bore and shaft arrangement
May, 2031

(6 years from now)

US10561808 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
Jan, 2032

(7 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Patient Population(NPP) Sep 16, 2011

Market Authorisation Date: 29 October, 2004

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

How can I launch a generic of PROAIR HFA before it's drug patent expiration?
More Information on Dosage

PROAIR HFA family patents

Family Patents

4. Proair Respiclick patents expiration

PROAIR RESPICLICK's oppositions filed in EPO
PROAIR RESPICLICK IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6446627 TEVA BRANDED PHARM Inhaler dose counter
Dec, 2017

(6 years ago)

US6718972 TEVA BRANDED PHARM Dose metering system for medicament inhaler
Jun, 2021

(2 years ago)

US8006690 TEVA BRANDED PHARM Reservoir pressure system for medicament inhaler
Jun, 2021

(2 years ago)

US6871646 TEVA BRANDED PHARM De-agglomerator for breath-actuated dry powder inhaler
Jun, 2021

(2 years ago)

US6701917 TEVA BRANDED PHARM Dose counter for medicament inhaler
Jun, 2021

(2 years ago)

US6748947 TEVA BRANDED PHARM De-agglomerator for breath-actuated dry powder inhaler
Jun, 2021

(2 years ago)

US7540282 TEVA BRANDED PHARM Reservoir pressure system for medicament inhaler
May, 2023

(1 year, 25 days ago)

US10765820 TEVA BRANDED PHARM Dry powder inhalation apparatus
May, 2025

(11 months from now)

US9463288 TEVA BRANDED PHARM Dry powder inhalation apparatus
May, 2025

(11 months from now)

US8651103 TEVA BRANDED PHARM Dry powder inhalation apparatus
Mar, 2028

(3 years from now)

US9731087 TEVA BRANDED PHARM Dose counter for inhaler having a bore and shaft arrangement
May, 2031

(6 years from now)

US10022510 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
May, 2031

(6 years from now)

US10124131 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(6 years from now)

US9216260 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
Jun, 2031

(7 years from now)

US10561808 TEVA BRANDED PHARM Dose counter for inhaler having an anti-reverse rotation actuator
Jan, 2032

(7 years from now)

US8978966 TEVA BRANDED PHARM Dose counters for inhalers, inhalers and methods of assembly thereof
Jan, 2032

(7 years from now)

US9782550 TEVA BRANDED PHARM Compliance monitoring module for a breath-actuated inhaler
Aug, 2035

(11 years from now)

US9782551 TEVA BRANDED PHARM Compliance monitoring module for a breath-actuated inhaler
Aug, 2035

(11 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Mar 12, 2018
New Patient Population(NPP) Apr 28, 2019

Market Authorisation Date: 21 December, 2018

Treatment: NA

Dosage: POWDER, METERED;INHALATION

More Information on Dosage

PROAIR RESPICLICK family patents

Family Patents

5. Proventil-hfa patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5605674 KINDEVA Medicinal aerosol formulations
Feb, 2014

(10 years ago)

US5775321 KINDEVA Seal configuration for aerosol canister
Jul, 2015

(8 years ago)

US6006745 KINDEVA Device for delivering an aerosol
Dec, 2016

(7 years ago)

Market Authorisation Date: 15 August, 1996

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

How can I launch a generic of PROVENTIL-HFA before it's drug patent expiration?
More Information on Dosage

PROVENTIL-HFA family patents

Family Patents

6. Ventolin Hfa patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6596260 GLAXOSMITHKLINE Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
Aug, 2014

(9 years ago)

US6596260

(Pediatric)

GLAXOSMITHKLINE Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
Feb, 2015

(9 years ago)

US6558651 GLAXOSMITHKLINE Aerosols containing annealed particulate salbutamol and tetrafluoroethane
Dec, 2016

(7 years ago)

US6558651

(Pediatric)

GLAXOSMITHKLINE Aerosols containing annealed particulate salbutamol and tetrafluoroethane
Jun, 2017

(6 years ago)

US6170717 GLAXOSMITHKLINE Valve for aerosol container
Dec, 2017

(6 years ago)

US6966467 GLAXOSMITHKLINE Valve for aerosol container
Dec, 2017

(6 years ago)

US6510969 GLAXOSMITHKLINE Valve for aerosol container
Dec, 2017

(6 years ago)

US6315173 GLAXOSMITHKLINE Valve for aerosol container
Dec, 2017

(6 years ago)

US6161724 GLAXOSMITHKLINE Indicating device
Jan, 2018

(6 years ago)

US6997349 GLAXOSMITHKLINE Indicating device
Jan, 2018

(6 years ago)

US6938796 GLAXOSMITHKLINE Indicating device
Jan, 2018

(6 years ago)

US6435372 GLAXOSMITHKLINE Delivery system for a medicament and method for the assembly thereof
Jan, 2018

(6 years ago)

US7143908 GLAXOSMITHKLINE Indicating device
Jan, 2018

(6 years ago)

US6431168 GLAXOSMITHKLINE Dispenser with doses′ counter
Jun, 2018

(5 years ago)

US7107986 GLAXOSMITHKLINE Dispenser with doses' counter
Jun, 2018

(5 years ago)

US6170717

(Pediatric)

GLAXOSMITHKLINE Valve for aerosol container
Jun, 2018

(5 years ago)

US6315173

(Pediatric)

GLAXOSMITHKLINE Valve for aerosol container
Jun, 2018

(5 years ago)

US6966467

(Pediatric)

GLAXOSMITHKLINE Valve for aerosol container
Jun, 2018

(5 years ago)

US6510969

(Pediatric)

GLAXOSMITHKLINE Valve for aerosol container
Jun, 2018

(5 years ago)

US6435372

(Pediatric)

GLAXOSMITHKLINE Delivery system for a medicament and method for the assembly thereof
Jul, 2018

(5 years ago)

US6938796

(Pediatric)

GLAXOSMITHKLINE Indicating device
Jul, 2018

(5 years ago)

US6997349

(Pediatric)

GLAXOSMITHKLINE Indicating device
Jul, 2018

(5 years ago)

US6161724

(Pediatric)

GLAXOSMITHKLINE Indicating device
Jul, 2018

(5 years ago)

US7143908

(Pediatric)

GLAXOSMITHKLINE Indicating device
Jul, 2018

(5 years ago)

US7350676 GLAXOSMITHKLINE Valve for aerosol container
Aug, 2018

(5 years ago)

US7107986

(Pediatric)

GLAXOSMITHKLINE Dispenser with doses' counter
Dec, 2018

(5 years ago)

US6431168

(Pediatric)

GLAXOSMITHKLINE Dispenser with doses′ counter
Dec, 2018

(5 years ago)

US7350676

(Pediatric)

GLAXOSMITHKLINE Valve for aerosol container
Feb, 2019

(5 years ago)

US9861771 GLAXOSMITHKLINE Device housing for an aerosol container
Oct, 2020

(3 years ago)

US6743413 GLAXOSMITHKLINE Suspension aerosol formulations
Jun, 2021

(2 years ago)

US6743413

(Pediatric)

GLAXOSMITHKLINE Suspension aerosol formulations
Dec, 2021

(2 years ago)

US7832351 GLAXOSMITHKLINE Actuation indicator for a dispensing device
Jun, 2023

(11 months ago)

US7832351

(Pediatric)

GLAXOSMITHKLINE Actuation indicator for a dispensing device
Dec, 2023

(5 months ago)

US7500444 GLAXOSMITHKLINE Actuation indicator for a dispensing device
Jan, 2025

(7 months from now)

US7500444

(Pediatric)

GLAXOSMITHKLINE Actuation indicator for a dispensing device
Jul, 2025

(1 year, 1 month from now)

Market Authorisation Date: 19 April, 2001

Treatment: The treatment or prevention of bronchospasm in adults and children 4 years of age and older with reversible obstructive airways disease and the prevention of exercised-induced bronchospasm in patients...

Dosage: AEROSOL, METERED;INHALATION

More Information on Dosage

VENTOLIN HFA family patents

Family Patents